AIPM to Participate in St.-Petersburg International Economic Forum

The Association of International Pharmaceutical Manufactures (AIPM) will actively participate in the XIV St.-Petersburg International Economic Forum on June 17-19, 2010, which for the first time will hold a session entitled “The Russian Pharmaceutical Sector – Investments for Innovative Development”.

The St.-Petersburg Forum has rightfully earned an international reputation and the status of Russia’s greatest economic event. Attendance by representatives of political and business quarters from all over the world is not only an indication of a growing interest in the event, but also a clear sign of readiness for mutual cooperation. Notably it is going to be the first Forum to hold a dedicated session on the pharmaceutical industry scheduled for June 19, 2010 in the ‘industry breakfast’ format.

The session will include an exchange of views on the most urgent challenges in the development of Russia’ pharmaceutical market. It will focus on localization of production facilities of international companies in the Russian Federation, R&D investment, preclinical and clinical data protection, international pricing policies for reimbursable pharmaceutical products, etc.

The ‘industry breakfast’ will be attended by representatives of governmental authorities and professional associations, CEOs of leading domestic and international pharmaceutical companies and distributors. Participating in the Forum’s activities will be senior executives of such pharmaceutical companies as AstraZeneca, Bayer Schering Pharma, Boehringer Ingelheim Pharma GmbH, GlaxoSmithKline, Novartis Group, Nycomed, Pfizer, Roche, Sanofi-aventis, and Stada CIS. According to IMS Health, potential participants in St.-Petersburg International Economic Forum account for around 30% of the world pharmaceutical market in terms of their 2009 performance.

A press briefing is scheduled following the conclusion of the session “The Russian Pharmaceutical Sector – Investments for Innovative Development”. Press-briefing will be held on June 19th at 10 am.